Ada Investment Management’s ResMed RMD Stock Holding History

Ada Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$244K	Sell	4,540 -1,978	-30%	-$111K	0.16%	267
2015 Q3	$368K	Buy	+6,518	New	+$351K	0.19%	196

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ada Investment Management's RMD Position: Q4 2015 in Review

Ada Investment Management reduced its ResMed (RMD) stake by 30% in Q4 2015, selling an estimated $111K and leaving 4,540 shares worth $244K. The position accounts for 0.16% of the portfolio, ranked #267.

Ada Investment Management first reported a position in RMD in Q3 2015 and has held it in 2 quarters since. The position peaked at $368K in Q3 2015. 351 funds tracked by Wall St. Rank hold RMD as of Q4 2015.

Ada Investment Management held 4,540 shares of ResMed worth $244K as of Q4 2015.
Ada Investment Management sold 1,978 ResMed shares in Q4 2015, an estimated $111K.
ResMed made up 0.16% of Ada Investment Management's portfolio in Q4 2015, its #267 holding.
Ada Investment Management first reported a position in ResMed in Q3 2015 and has held it in 2 quarters since.
Ada Investment Management's ResMed position peaked at $368K in Q3 2015.
351 funds tracked by Wall St. Rank held ResMed as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.